'From the first beginning of our knowledge of man, we find him consuming substances of no nutritive value, but taken for the sole purpose of producing for a certain time a feeling of contentment, ease and comfort', wrote the famous German pharmacologist Lewis Lewin in his highly cited text Phantastica, narcotic and stimulating drugs [1] . Lewin continues to discuss nicotine and quotes a seventeenth century Dutch physician, Bontekoe: 'Nothing is more necessary and beneficial to life and health than the smoke of tobacco. It gladdens the heart in solitude and relieves a sedentary life of all discomforts'. The inhalation of tobacco smoke is not so enthusiastically endorsed by the medical profession these days, although leading figures in the tobacco industry have continued to deny harms. For example, Thomas Sandefur, Chairman and CEO of Brown & Williamson Tobacco Corporation (a subsidiary of British American Tobacco), testified in the US House of Representatives: 'I do not believe that nicotine is addictive . . . nicotine is a very important constituent in the cigarette smoke for taste' [2] . However, the conclusion of a US Institute of Medicine Committee established to assess the scientific basis for tobacco harm reduction reads: 'Scientific evidence establishes unequivocally that tobacco use causes serious adverse health effects in humans and that the nicotine delivered by tobacco is a highly addictive drug' [3] .
As data have been accumulating from the middle of last century attesting to the negative impact on health from both directly smoking cigarettes as well as being exposed to 'second-hand' smoke, there has been an increasing tightening of government policy in terms of decreasing accessibility of smoking in public places in developed This issue of the Australian and New Zealand Journal of Psychiatry contains two articles specifically related to cigarette smoking in psychiatric inpatient settings, where there has long been a shared culture of smoking by both staff and patients [4, 5] . However, as public health measures have taken effect over the past 20-30 years, the rate of cigarette smoking among the general public including clinical staff, has dropped about 10-15%, greater than the rate of reduction among patients. Psychiatric patients now begin to make up a significant proportion of the adult smoking citizens in Australia and New Zealand; overall rates of which are 20% and 25%, respectively, in the two countries [6, 7] . Whereas smoking has been a vehicle for various forms of social cohesion between staff and patients in the past, it has changed to becoming a source of concern, as the health risks of smoking, including passive smoking, have become increasingly known. This disquiet could quite possibly escalate as the risk of litigation increases, related to staff and patients declaring they developed serious health problems, including addiction to nicotine, as a result of their time spent in psychiatric hospitals.
However, it is disappointing that it might take litigation of this nature for psychiatry to wake up to the reality of nicotine dependence as an important mental disorder of our times, worthy of serious clinical attention. Even though the majority of patients accessing psychiatric services are nicotine dependent (50-90%) [8] , and despite clear diagnostic description and definition of nicotine dependence as a mental disorder [9] , it is not common for nicotine dependence to feature in either the diagnostic formulation or the management plan of patients in written psychiatric reports.
So what can be done about the clinical neglect of nicotine dependence as a mental disorder by psychiatric teams? Actively supporting smoking bans in psychiatric settings is clearly part of the answer, and the 14 measures outlined in the article of Lawn and Pols [4] offer positive steps forward in this regard. However, there is now opening up an opportunity for psychiatry to embrace nicotine dependence as a leading mental disorder of our age; as the neurobiology of addiction continues to unravel [10] , the genetic basis of externalized mental disorders including nicotine dependence becomes clearer [11] and treatments for nicotine dependence become increasingly refined and effective [12] . Developing an appropriate clinical arm involving both primary and secondary treatment services, and working in concert with ongoing public health strategies, just might obviate Lewin's dire warning: 'Tobacco has surpassed the limits of a medical plant. It has penetrated far into the world and among mankind . . . . The use of tobacco has vanquished humanity and will continue to reign until the end of the world' [1] .
